-

Lost Money on Everest Group, Ltd. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 11.4% Share Price Drop

Investigation follows the October 27, 2025 disclosure regarding Everest Group, Ltd.; investors who lost money may have claims to recover their losses

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Everest Group, Ltd. ("Everest" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Everest Group, Ltd. (NYSE: EG) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 27, 2025 disclosure regarding Everest Group, Ltd.

Investors who lost money on Everest Group, Ltd. securities can submit their Everest Group, Ltd. loss information to learn about potentially pursuing claims to recover their losses.

Key facts in the Everest Group, Ltd. investigation

  • Disclosure date: October 27, 2025
  • Stock price decline: $39.07 per share, or 11.4%
  • Closing price after the decline: $304.91 on October 28, 2025

What happened?

On October 30, 2024, Everest released its third quarter 2024 results and disclosed that loss activity in its U.S. casualty business had “definitely spiked” and that rate increases had accelerated into the high teens. Everest further disclosed that its annual casualty reserve review was underway and would be completed during the fourth quarter.

On this news, Everest stock fell $24.39 or 6.42%, to close at $355.61 per share on October 31, 2024, thereby injuring investors.

Then, on January 27, 2025, Everest announced $1.7 billion in reserve strengthening, including approximately $1.3 billion related to U.S. casualty losses in Everest’s Insurance segment, principally from accident years 2020 through 2024. Its new Chief Executive Officer (CEO) acknowledged that Everest's underwriting choices contributed significantly to the losses.

On this news, Everest stock fell $21.49 or 5.8% over the following two consecutive trading days, to close at $351.51 per share on January 29, 2025, thereby further injuring investors.

Then, on October 27, 2025, Everest disclosed $478 million in unfavorable prior-year reserve development, driven principally by U.S. casualty losses. Everest also entered into an agreement providing $1.2 billion in protection against further adverse development on approximately $5.4 billion of North American Insurance and Other segment reserves for accident years 2024 and prior.

On this news, Everest stock fell $39.07 or 11.4%, to close at $304.91 per share on October 28, 2025, further injuring investors.

"The price of Everest Group, Ltd. shares fell 11.4% following the October 27, 2025 disclosure that Everest had recorded $478 million in unfavorable prior-year reserve development, driven principally by U.S. casualty losses, and had entered into an agreement providing $1.2 billion in protection against further adverse development on approximately $5.4 billion of reserves. Investors who suffered losses deserve to know whether they were given complete and accurate information prior to the disclosure, and our investigation seeks to answer that question," said Charles H. Linehan, Partner at Glancy Prongay Wolke & Rotter LLP.

What's the next step?

Glancy is investigating potential claims on behalf of Everest Group, Ltd. investors. Investors who lost money can contact Glancy about the Everest Group, Ltd. investigation, email shareholders@glancylaw.com, or call 310-201-9150 (toll-free: 888-773-9224).

Frequently Asked Questions

Who is eligible? Investors who bought Everest Group, Ltd. securities and lost money may have claims, and can contact Glancy to learn whether they are affected by the Everest Group, Ltd. investigation.

What is a securities fraud investigation? In the Everest Group, Ltd. investigation, Glancy is reviewing whether the Company or its executives may have made false or misleading statements to investors in violation of the federal securities laws.

Has a lawsuit been filed? This release announces Glancy's investigation, not a lawsuit. If a securities class action is later filed against Everest Group, Ltd., investors may have the opportunity to seek appointment as lead plaintiff.

Does it cost anything to contact Glancy or participate in this investigation? Glancy represents Everest Group, Ltd. investors on a contingency fee basis, so investors pay no attorneys' fees out of pocket. Any attorneys' fees and litigation expenses are paid only from a recovery, if one is obtained, and are subject to court approval.

Why work with Glancy on the Everest Group, Ltd. investigation? Glancy Prongay Wolke & Rotter LLP is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Contact Glancy about the Everest Group, Ltd. investigation. Prior results do not guarantee a similar outcome.

Whistleblower notice

Persons with non-public information about Everest Group, Ltd. should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information that leads to a successful SEC enforcement action may receive awards of 10 to 30 percent of the sanctions collected, when those sanctions exceed $1 million. For more information, contact Charles H. Linehan at 310-201-9150 or 888-773-9224, or email shareholders@glancylaw.com.

About Glancy Prongay Wolke & Rotter LLP

Glancy was named one of Law360's Securities Groups of the Year and ranked second in total investor recoveries by ISS Securities Class Action Services in 2025.

Glancy's successes have been widely covered by leading news and industry publications, including The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money.

Prior results do not guarantee a similar outcome.

Related links

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Charles H. Linehan
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150 | Toll-free: 888-773-9224
www.glancylaw.com
Follow Glancy on LinkedIn, X, or Facebook.

Glancy Prongay Wolke & Rotter LLP

NYSE:EG

Release Versions

Contacts

Charles H. Linehan
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150 | Toll-free: 888-773-9224
www.glancylaw.com
Follow Glancy on LinkedIn, X, or Facebook.

More News From Glancy Prongay Wolke & Rotter LLP

Lost Money on Merck & Co., Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 1.76% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Merck & Co., Inc. ("Merck" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Merck & Co., Inc. (NYSE: MRK) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding Merck & Co., Inc.Investors who lost money on Me...

Lost Money on Tenax Therapeutics, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 89.77% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Tenax Therapeutics, Inc. ("Tenax" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Tenax Therapeutics, Inc. (NASDAQ: TENX) investors into whether the Company may have violated the federal securities laws. The investigation follows the August 10, 2026 disclosure regarding Tenax Therapeutics, Inc. Investors who los...

Deadline Alert: D-Wave Quantum, Inc. Investors Have Until December 15, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

LOS ANGELES--(BUSINESS WIRE)--Investors in D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) have until December 15, 2026 to ask the Court to appoint them lead plaintiff in a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired D-Wave Quantum, Inc. securities between February 26, 2026 and August 25, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today reminded investors of the upcoming deadline. The D-Wave Quantum...
Back to Newsroom